|
Two molecular imaging radiopharmaceuticals that bind specifically to
prostate-specific membrane antigen, a protein that is
over-expressed on the surface of prostate cancer cells, demonstrated
efficacy for diagnosing and staging prostate cancer, according to
research presented at the Society of
Nuclear Medicine (SNM) annual conference this week in New Orleans.
|
|
more...
|
Previous 